Katherine A. Foss (Ph.D., Mass Communication, University of Minnesota), is professor of Media Studies in the School of Journalism & Strategic Media at Middle Tennessee University and an award-winning scholar. Her research broadly examines facets of health communication, including the history of media and epidemics, breastfeeding discourse, and parasocial interactionism and grief. Previous studies have addressed children’s media literacy, gender and victimization, hearing loss, and other topics related to entertainment media.
She is the author of Constructing the Outbreak: Epidemics in Media and Collective Memory (University of Massachusetts Press, forthcoming), a book that encompasses more than 200 years of media coverage of epidemics. Past books also include Breastfeeding and Media: Exploring Conflicting Discourses That Threaten Public Health (2017, Palgrave Macmillan), and Television and Health Responsibility in an Age of Individualism (2014, Lexington Books). She has also produced more than two dozen publications that include op-eds, essays, reviews, book chapters, encyclopedia entries, and peer-reviewed articles in Journalism & Mass Communication Quarterly, Health Communication, Critical Studies in Media Communication, and other journals. Foss also served as the editor for The Graduate Student Guidebook: From Orientation to Tenure Track (forthcoming, Rowman & Littlefield), Beyond Princess Culture: Gender and Children’s Marketing (2019, Peter Lang Publishing) and Demystifying the Big House: Exploring Prison Experience and Media Representations (2018, Southern Illinois Press University).
She serves as the on the Board of Directors for the Association of Education in Journalism & Mass Communication and on the editorial boards of Health Communication and the Image of the Journalist in Popular Culture. She was an invited speaker at the 2012 Great Nurse-In, a breastfeeding advocacy event held on the West Lawn of Capitol Hill in Washington, D.C. She also won the 2013 Covert Award and the 2012 James W. Carey Media Research Award and the for her co-authored article (with Dr. Kathy Forde) published in Book History.
"Pick the products that are supposedly either for men or gender neutral as opposed to the ones that are 'pinkified' or orientated towards women our girls," ,"Attention to how media messages address the virus, its transmission and risk varied significantly across types of coverage and by the nation that produces it," ,“The most alarming messages have come from just people speculating on social media and other people taking that as fact.”
Dr. Clair Francomano has been involved in the care of individuals with the Ehlers-Danlos Syndromes throughout her career. During her years at the National Institutes of Health, she spear-headed a longitudinal study on the natural history of EDS that ran for over 20 years. She has served on the Steering Committee for the International Consortium on the Ehlers-Danlos Syndromes and Related Conditions and as chair of the Committee on Classical Ehlers-Danlos Syndrome for the Consortium since 2016.
Dr. Francomano joined Indiana University in August 2019 as professor of medical and molecular genetics at the IU School of Medicine and director of the Residency Training Program in Genetics at IU. Prior to joining IU, she was the director of the Ehlers-Danlos National Foundation Center for Clinical Care and Research at the Harvey Institute of Human Genetics, Greater Baltimore Medical Center, which she joined in 2005 as director of adult genetics
Dr. Francomano's research interests over the years have centered on hereditary disorders of connective tissue and skeletal dysplasias. In 1994, she became Chief of the Medical Genetics Branch at the National Human Genome Research Institute, National Institutes of Health, where she served as Clinical Director from 1996-2001. From 2001-2005 she was Chief of the Human Genetics and Integrative Medicine Section in the Laboratory of Genetics, National Institute on Aging. She has published over 130 peer-reviewed articles and lectures widely around the world about the Ehlers-Danlos Syndromes and related disorders. She has a keen interest in the management of the multiple co-morbidities seen in this condition.
Dr. Francomano attended Yale College as an undergraduate and received her M.D. from Johns Hopkins University School of Medicine, where she trained in internal medicine and medical genetics. She joined the full-time Hopkins faculty in 1984.
“A lot of people hear that it’s all in their head, and that there is no physiologic basis for their symptoms,” Francomano said. “Particularly if they’re healthy-looking young women, unfortunately there is a tendency to dismiss their experience.”,“So many patients are finding their diagnosis by looking it up,” Francomano said. “They put their symptoms into Google and those lead to the Ehlers-
Danlos National Foundation and videos by Dr. Henderson and myself and other doctors. They find us.”
Dr. Frazier completed a neurosurgical residency at the Johns Hopkins Hospital after earning a medical degree from the Johns Hopkins University School of Medicine and an undergraduate degree magna cum laude from Brown University in Providence, Rhode Island. As a medical student, Dr. Frazier received the Hunterian Medical Student Research Award for his work on interstitial chemotherapy for brain tumors. During his training, Dr. Frazier completed specialized fellowships in neuro-oncology and radiosurgery.
Hudson Freeze helps doctors and families get often long-awaited answers about their child’s rare disease. His lab focuses on developing tests for congenital disorders of glycosylation, or CDGs, an umbrella term for more than 140 mutations that disrupt sugar linking.
First discovered in the 1990s, children with CDG have varying degrees of speech and language difficulty, poor balance, motor control, vision problems, hearing impairments and seizures.
Remarkably, children with two specific CDG mutations who receive simple nutritional supplements can have dramatic symptom improvements—sometimes even living relatively normal lives. However, for the remaining 140 mutations, no treatments exist.
,“You likely have a loved one, friend, neighbor, colleague or someone else in your life who has a rare disorder,” Freeze said. “Rare Disease Day is an important day to speak out and educate ourselves about this large group of unexpectedly common conditions,"Before this study doctors just knew the physical symptoms of Saul-Wilson, and the name of the disease. This study showed us the gene that is involved and the molecular cause of the condition. Now we know the exact underlying cause of the disorder."
Emily Frye is Director for Cyber Integration at the Homeland Security Center at The MITRE Corporation. She is an expert on homeland security, critical infrastructure and cybersecurity.
Frye’s work has helped define and explore options for the future of comprehensive, nationwide cybersecurity approaches across both public and private sectors, bridge the divide between federal and state government on cybersecurity initiatives, and strengthen public-private partnerships in support of critical infrastructure security and resilience.
Frye has served on both the Long-Range Planning Committee for the Section of Science & Technology of the American Bar Association, and as advisor to the Diversity Committee of the American Bar Association. She is an accomplished speaker and moderator, and has written about issues relating to critical infrastructure, national resilience, digital technology, national security, privacy, economic impacts of cybersecurity, and the role of insurance in Critical Infrastructure Protection. She received her Doctor of Jurisprudence degree from George Mason University and her undergraduate degree from William & Mary.
Her speaking appearances include a cybersecurity conference hosted by the Atlantic Council in Poland and Xconomy’s Cyber Madness. She has also written in The Hill on the need for an international cyber court, and been quoted by Slate and CybersecurityTV.
Charles S. Fuchs, MD, MPH, became Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital on January 1, 2017. An internationally recognized expert in gastrointestinal cancers and cancer epidemiology, Dr. Fuchs was previously profess
The biology of colon cancer presents unique challenges that are distinct from other cancers. It doesn’t avail itself as other cancers do to current cancer drugs.”
Larry Fulton is an Associate Professor of Health Administration at Texas State University, San Marcos. He earned his Doctorate of Philosophy / Masters of Science in Statistics from the University of Texas at Austin, his Master of Health Administration from Baylor, and three other graduate degrees. Dr. Fulton is a Fellow of the American College of Healthcare Executives (FACHE) and maintains the credentials of Chartered Scientist and Chartered Statistician (CStat CSci) as a Fellow in the Royal Statistical Society. He is a Certified Analytics Professional (CAP) of the Institute for Operations Research & Management Science, a Certified Quality Engineer and Certified Six Sigma Black Belt (CQE CSSBB) of the American Society for Quality and a Professional Statistician (PStat) of the American Statistical Association.
As the opioid epidemic continues, understanding the geospatial, temporal, and demand patterns is important for policymakers to assign resources and interdict individual, organization, and country-level bad actors.
Robert Garofalo, MD, MPH, is the Division Head of Adolescent Medicine at Ann & Robert H. Lurie Children’s Hospital of Chicago and a Professor of Pediatrics at Northwestern University Feinberg School of Medicine. He is a Co-Director of Lurie Children’s Gender and Sex Development Program, the first comprehensive program for gender nonconforming children and adolescents in the Midwest. Dr. Garofalo also directs Lurie Children’s Adolescent/Young Adult HIV Program and the Center for Gender, Sexuality and HIV Prevention, which conducts research on topics in adolescent sexual health, gender, sexuality, HIV prevention and health disparities affecting adolescent and young adult populations at risk of acquiring HIV. He is a national expert on lesbian, gay, bisexual and transgender (LGBT) health issues in youth, as well as adolescent sexuality and HIV clinical care and prevention. Dr. Garofalo is the former President of the Gay and Lesbian Medical Association. In 2010, he served as a committee member for the National Academy of Sciences/Institute of Medicine Committee on Lesbian, Gay, Bisexual and Transgender Health Issues and Research Gaps and Opportunities.
Garruto’s research interests include natural experimental models of disease, using both field and laboratory approaches. His cross-disciplinary research and interests include studies of neurodegenerative disorders including amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease, food chain disorders, health transition studies, obesity and bionutrition, malaria, Lyme and other tick-borne diseases, and prion diseases, especially chronic wasting disease.
Dr. Gauduin has more than 25 years of experience in HIV/AIDS research and medical microbiology. She has been working extensively on HIV and the development of novel vaccine strategies using the non-human primate model for AIDS. In her work, she uses epithelial stem cells and weakened recombinant papillomavirus as vaccine- vectors to protect against multiple low-dose mucosal challenges. Dr. Gauduin is also developing a neonatal model for tuberculosis to study HIV/TB co-infection in pediatric AIDS.
Her specific research interests are:
Early events of simian immunodeficiency virus (SIV) transmission in a macaque model
Host immune responses to infectious diseases
Early virus-specific T cell responses in neonates
Tuberculosis/SIV coinfection in pediatric AIDS
Michael Giberson is an associate professor of practice in the Jerry S. Rawls College of Business at Texas Tech University. He is an expert in the areas of energy economics, U.S. energy policy and the electric power industry. Giberson's research and writing focuses on U.S. energy policy and electric power markets, and on the law and economics of price gouging. He is a faculty affiliate at the Free Market Institute at Texas Tech University. Prior to joining Texas Tech in 2008 he worked with Potomac Economics, Ltd., an economic consulting firm specializing in the electric power industry. Michael Giberson has been published in Nature Energy, the Electricity Journal, the Journal of Regulatory Economics, the Pacific and Asian Journal of Energy, and Regulation magazine, and has written on U.S. energy policies and federal electric power issues for trade publications. He is co-author with Lynne Kiesling of the Knowledge Problem blog discussing economics, energy policy, technology and many other topics. Energy posts at Knowledge Problem are included at Social Media Today's The Energy Collective online community. In addition, his commentary and analysis has appeared at Alternative Energy Stocks and MasterResource. Giberson earned his bachelor's degree in economics from Texas Tech and his master's and doctorate degrees in economics from George Mason University.
Harvinder Gill is a graduate advisor, associate professor and Whitacre Endowed Chair of Science and Engineering in the Department of Chemical Engineering within the Texas Tech University Edward E. Whitacre Jr. College of Engineering. He directs the Gil Lab where he and his colleagues perform fundamental and translational research in the fields of drug delivery, vaccines, immunotherapy, and nanomedicine to help address some of the pressing biomedical challenges facing human health. His research integrates the knowledge and tools from various disciplines including engineering, chemistry, biology, immunology, recombinant engineering, and micro-nano-technology. Gill currently works to discover innovative drug and vaccine delivery platforms aimed at maximizing stimulation of mucosal immunity in order to address the challenges related to influenza and HIV infectious diseases as well as developing a delivery system for localized delivery of cancer drugs directly into oral tumors. Dr. Gill also is working on developing a delivery method to eliminate peanut allergies through a grant from the NIH, working to transform pollen grain shells into vehicles for delivery of allergy vaccines, and using microneedles to eliminate the need for regular needles to deliver vaccines. Gill earned his bachelor's degree in chemical engineering from Panjab University in 1994 and his doctorate in bioengineering from the Georgia Institute of Technology in 2007.
URI’s Isaac Ginis uses computer model to predict the power of storms.
The 2019 hurricane season officially kicked off June 1. Predicting the severity of a hurricane can mean the difference between life and death. URI Professor of Oceanography Isaac Ginis makes it his business to predict the power of these ferocious storms with a computer model so successful it was adopted by the National Weather Service.
Ginis’s research efforts have resulted in pioneering advances in modeling of the tropical cyclone-ocean interactions that have led to significant improvements in hurricane intensity forecast skills.
Ginis’s research group has contributed to the development of the HWRF hurricane model used by the U.S. National Hurricane Center and Joint Typhoon Warning Center for operational forecasting of tropical cyclones in all ocean basins. He is currently leading a project funded by the U.S. Department of Homeland Security Coastal Resilience Center of Excellence to develop advanced modeling capabilities for more accurate representation of hurricane hazards and impacts in Southern New England. This project allows DHS and other agencies to better understand the consequences of coastal and inland hazards associated with extreme hurricanes and Nor’easters and to better prepare coastal communities for future risks.
“We’re working to improve existing models and create new modeling capabilities to address concerns about coastal flooding due to storm surge, inland flooding due to heavy rainfall and the challenges of predicting winds over land,” Ginis said.
In 1993, Antonio Giordano, M.D., Ph.D., founded the Sbarro Institute with a generous donation from Mario Sbarro, the Founder of the Sbarro restaurant chain, following Dr. Giordano’s discovery of the tumor suppressor gene pRb2. Initially named the Sbarro Institute, the research center was located at Thomas Jefferson University, where Dr. Giordano was a professor.
When Dr. Giordano moved to Temple University in 2002, he and twenty fellow scientists forged a new, three-year alliance with Temple University in Philadelphia, Pennsylvania. Under the new arrangement, the original Sbarro Institute was renamed the Sbarro Health Research Organization, Inc. (SHRO), which includes the Sbarro Institute for Cancer Research and Molecular Medicine at Temple and the SHRO-affiliated laboratory at the University of Siena in Siena, Italy.
Under a 2005 agreement, the Sbarro Institute for Cancer Research and Molecular Medicine received continued funding from Temple and expanded its program to include work on the relationship between obesity and cancer and instituted a new program on molecular therapeutics to explore how molecular genetic research can be applied to patient therapies and diagnostics.
SHRO relies on grants and private donations to fund important biomedical research.
Before joining UCLA, Giza worked on the Yosemite Search and Rescue team. In 2011, he traveled to Afghanistan as a civilian advisor to the U.S. Department of Defense. He co-chaired the American Academy of Neurology committee that developed an evidence-based practice guideline for the management of sports concussions from 2009-2013. He currently serves on advisory committees for traumatic brain injuries/concussion with the U.S. Centers for Disease Control, National Collegiate Athletic Association, Major League Soccer and U.S. Soccer Federation. He has been a clinical consultant for the National Football League, National Hockey League and Major League Soccer.
“One thing that is a little surprising,” he said, “is that the objective measures of disrupted sleep showed differences after [traumatic brain injury], but the subjects themselves underestimated their sleep disturbances.”
“There are cases out there, unfortunately, of people who were convinced they had CTE and committed suicide, and then were found in autopsy not to have CTE.” ,“We should keep our minds open,” said Giza, who advises several professional athletic associations on traumatic brain injury, “or we may miss out on some of the science.”
,“Concussions are the most complex injury to the most complicated organ in the human body. There is no magic-bullet, catch-all test for diagnosing the disorder.”
Dr. Baron is currently an Associate Professor in the Division of Public Health, Department of Family and Preventive Medicine. She is a clinical psychologist with specialty training in Behavioral Sleep Medicine.
Dr. Baron completed her bachelor's degree with honors and distinction at the Ohio State University. She completed her master's degree and Ph.D. in clinical psychology at the University of Utah. Her predoctoral residency in health psychology was completed at Rush University Medical School. After graduate school, she completed a postdoctoral fellowship in health services research as well as an MPH degree at Northwestern University. Prior to her position at the University of Utah, Dr. Baron held faculty positions at the Feinberg School of Medicine at Northwestern University and Rush University Medical School.
Dr. Baron is involved in sleep research as well as providing non-drug treatment for sleep disorders. In the clinic, she provides Cognitive Behavioral Therapy for Insomnia (CBT-I), the most effective treatment for chronic insomnia. She also delivers cognitive and behavioral treatment for other sleep disorders including circadian disorders, problems using CPAP treatment in sleep apnea, nightmares, sleepwalking, and coping with disorders of excessive sleepiness such as narcolepsy.
Dr. Baron also translates her passion for the science of sleep and sleep disorders treatment as the director of the behavioral sleep medicine training program and is enthusiastic about increasing the training and awareness of non-drug treatments for sleep disorders because they are highly effective at improving sleep and quality of life.
Her research has been supported by the NIH, including the completion of a K23 mentored patient-oriented research award and a current 5 year R01 research project examing the role of sleep and circadian disruption on appetite regulation. Dr. Baron's research has been widely covered by the press including being featured in the press such as the New York Times, Cooking Light, Men's Health, Webmd.com, Wirecutter.com, and US News and World Report.
“I want our culture to change so that we respect that we need night workers and we need early morning workers. People should have some ability to choose their shift or to have productive hours when they feel the most productive and in line with their circadian rhythm when it's possible.”
,“One of the things that we’re hoping to do in our research is to reach outside the university community, even more than we typically do, in our sleep research and reach out to communities and have a broad representation of people participating in our study.”,“One of the best things you could do is just have a culture where you don’t send emails at night,” said Baron, “or where you incentivize people [against] being glued to their laptops all the time.”
A large tongue size can be linked to sleep apnea, a condition where people have lapses in breathing while sleeping, according to Dr. Kelly Glazer Baron, director of the Sleep-Wake Center at the University of Utah.,"There has been more and more research in the last decade showing exercise can reduce insomnia,",Dr. Kelly Baron, one of the paper’s authors and the director of the University of Utah’s behavioral sleep medicine program, said that sleep trackers can be helpful in identifying patterns. She herself tracks her bedtime with a Fitbit.
Assistant Professor of Politics at Cornell College in Mount Vernon, Iowa. Ph.D. in 2019 from the department of political science at the Massachusetts Institute of Technology, graduate student affiliate of the MIT Political Methodology Lab. Studies American politics, focusing on state politics, political messaging, public opinion, and quantitative methodology.
Her work examines the dynamics of state politics in an increasingly nationalized context. Studies how governors and state parties shift their rhetoric towards elections, and how the mass public reacts to such shifts. Looks for changes in ideological heterogeneity among political elites as elections approach, and how often governors use national politics to frame issues. Finally, examines the public’s response to the governor’s “going national.” Uses social media data, text analysis, and survey experiments to answer these questions.
Research addresses the relevance and consequences of a federal system when it comes to state politics and political behavior. This question is increasingly important as we are faced with evidence that state political idiosyncrasies are disappearing.
Methodologically, work looks to bring text and social media to answer this question in ways we are unable to do with existing data sources, such as state of the state addresses or state party platforms.
“The structural organization of the U.S. makes it really hard for a third party to ever actually gain any traction,”
Professor of medicine at Georgetown University Medical Center. A member of the Institute of Medicine, Goodman is trained in infectious diseases and public health. He formerly served as the U.S. Food and Drug Administration Chief Scientist and Deputy Commissioner. He worked extensively on emerging infectious diseases at FDA and with the U.S. Department of Health and Human Services and has served as an advisor to the World Health Organization and others on medical countermeasures and vaccines. Goodman is director of the Center on Medical Product Access, Safety and Stewardship (COMPASS) at Georgetown and a clinician at MedStar Georgetown University Hospital, the Washington D.C. VA Medical Center and Walter Reed National Military Medical Center.
Ernest Goss is the Jack MacAllister Chair in Regional Economics at Creighton University and served as the initial director for Creighton’s Institute for Economic Inquiry. He is also principal of the Goss Institute in Denver, Colo. Goss received his Ph.D. in economics from The University of Tennessee in 1983 and is a former faculty research fellow at NASA’s Marshall Space Flight Center. He was a visiting scholar with the Congressional Budget Office for 2003-2004, and has testified before the U.S. Congress, the Kansas Legislature, and the Nebraska Legislature. In the fall of 2005, the Nebraska Attorney General appointed Goss to head a task force examining gasoline pricing in the state.
Faculty director of the O’Neill Institute for National and Global Health Law at Georgetown Law. He is professor of medicine at Georgetown University School of Medicine and professor of public health at the Johns Hopkins University. Gostin is a co-director of the World Health Organization Collaborating Center on National and Global Health Law and has served on numerous WHO expert advisory committees related to public health and global health security. Gostin serves on the Independent Panel on the Global Response to Ebola (Harvard University/London School of Hygiene and Tropical Medicine) and served on the National Academy of Medicine’s Commission on a Global Health Risk Framework for the Future.